Medical Journal Calls for a New Drug Watchdog
75445
The United States needs a better system to detect harmful effects of drugs already on the market, and it should be independent of the Food and Drug Administration and the drug industry, medical
150048
The Food and Drug Administration will establish a new independent Drug Safety Oversight Board to monitor FDA-approved medicines once they're on the market and update physicians and patients with emerging information on risks and benefits.
270368
Merck &amp; Co.&#39;s recall of the Vioxx painkiller shows why the US Food and Drug Administration needs its safety monitors to be independent of those who approve new medicines, FDA scientist David J. Graham told a Senate hearing.
386658
The U.S. Food and Drug Administration is facing new questions about its ability to police the safety of medicines after they reach the market following concerns about a widely used diabetes drug.
265006
U.S. lawmakers and health officials  are moving to give more independence to an office that reviews  drug safety, but some experts say ensuring medicines are  studied after they hit the market is more important than the  bureaucratic pecking order.
680573
European medicines watchdogs are to consider whether doctors need more warnings about the use of a drug to treat rheumatoid arthritis after an alert in the US by its manufacturers.
598332
The FDA will review its new cholesterol drug.
17863
A survey of hospital review boards that watchdog experiments on patients shows that one in three members takes money from companies that make drugs and medical devices that come under study. What's more, many of those with conflicts rarely or never disclose their financial ties, researchers found.
17230
Scientists in the United States and Great Britain are calling for a fresh look at Celebrex and other medications similar to Vioxx, the heavily advertised arthritis
710705
Leading medical journal editors and lawmakers have rightfully focused a spotlight on how well the Food and Drug Administration monitors the safety of drugs after they are approved.
622142
LEADING medical journal editors and lawmakers have rightfully focused a spotlight on how well the Food and Drug Administration monitors the safety of drugs after they are approved.
124030
Almost one-fifth of the Food and Drug Administration scientists surveyed two years ago as part of an official review said they had been pressured to recommend approval of a new drug despite
54539
WASHINGTON - The US pharmaceutical industry that exports billions of dollars worth of medicine around the world faced new scrutiny Friday after a survey revealed nearly one-fifth of its government overseers had experienced pressure to approve drugs they
314104
The U.S. Food and Drug Administration said on Tuesday it was creating an independent drug safety board after the agency's monitoring of drugs already in the marketplace was criticized amid the withdrawal of arthritis drug Vioxx.
357107
The debate over the disclosure of clinical drug trials could reach a turning point this week, with editors of influential medical journals expected to call for fundamental changes.
159888
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way it monitors safety risks associated with medicines already  on the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
430204
Dr. David J. Graham, the FDA drug safety reviewer who sounded warnings over five drugs he felt could become the next Vioxx has turned to a Whistleblower protection group for legal help.